Valeritas Holdings, Inc. (NASDAQ:VLRX) shares reached a new 52-week low on Tuesday . The company traded as low as $2.05 and last traded at $2.05, with a volume of 7,586 shares. The stock had previously closed at $2.27.

A number of research analysts have weighed in on VLRX shares. Wedbush started coverage on shares of Valeritas Holdings in a research note on Monday, July 10th. They issued an “outperform” rating and a $12.00 target price on the stock. ValuEngine lowered shares of Valeritas Holdings from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 19th.

The stock’s market capitalization is $15.74 million. The stock has a 50 day moving average price of $3.16 and a 200 day moving average price of $5.04.

Valeritas Holdings (NASDAQ:VLRX) last announced its quarterly earnings data on Friday, August 11th. The company reported ($1.83) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.87) by $0.04. The firm had revenue of $4.79 million for the quarter, compared to analysts’ expectations of $5.11 million. Analysts forecast that Valeritas Holdings, Inc. will post ($8.60) earnings per share for the current fiscal year.

A hedge fund recently bought a new stake in Valeritas Holdings stock. C WorldWide Group Holding A S acquired a new stake in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned 3.42% of Valeritas Holdings as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 6.01% of the company’s stock.

WARNING: “Valeritas Holdings, Inc. (VLRX) Hits New 52-Week Low at $2.05” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at

About Valeritas Holdings

Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.

Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.